Afuco™ Anti-MET ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H24)

CAT#: AFC-TAB-H24

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Humanized (from mouse) antibody to Human MET

Gene Expression
Figure 1 IF staining of human cell line U-251 MG Figure 2 IF staining of human cell line A-431 Figure 3 IF staining of human cell line U-2 OS Figure 4 Kidney Figure 5 Testis Figure 6 RNA cell line category: Cell line enhanced (A-431, CAPAN-2)

Specifications

  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Specificity
  • MET (met proto-oncogene, hepatocyte growth factor (HGF) receptor, HGFR, scatter factor (SF) receptor, HGF/SF receptor, receptor tyrosine-protein kinase c-met, papillary renal cell carcinoma 2, RCCP2) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Emibetuzumab
  • Related Disease
  • Solid tumors, advanced or metastatic

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • MET; met proto-oncogene (hepatocyte growth factor receptor); hepatocyte growth factor receptor; HGFR; RCCP2; SF receptor; HGF receptor; oncogene MET; HGF/SF receptor; proto-oncogene c-Met; scatter factor receptor
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-H24. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Emibetuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Emibetuzumab.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Emibetuzumab"

DrugMonitor™ Anti-Emibetuzumab Antibody (VS-1224-YC418)
Emibetuzumab has been evaluated in clinical trials for advanced cancer, including renal cell carcinoma, hepatocellular cancer, gastric adenocarcinoma, and non-small cell lung cancer. The DrugMonitor™ Anti-Emibetuzumab Antibody (VS-1224-YC418) is an anti-drug antibody (ADA) against Emibetuzumab. This drug-based antibody is raised in mice immunized with the Emibetuzumab. The anti-Emibetuzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Emibetuzumab in samples.

See other products for "MET"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
AGTO-G049E Anti-MET immunotoxin (Fab)-PE Cytotoxicity assay, Function study
CAT Product Name Application Type
PABZ-155 Afuco™ Anti-MET ADCC Recombinant Antibody, ADCC Enhanced (PABZ-155) ELISA, Neut ADCC enhanced antibody
CAT Product Name Application Type
TAB-002MZ Anti-Human MET Recombinant Antibody (TAB-002MZ) IHC, PET imaging Chimeric antibody (mouse/human)
TAB-002MZ-S(P) Anti-Human MET Recombinant Antibody scFv Fragment (TAB-002MZ-S(P)) IHC, PET imaging Chimeric antibody (mouse/human)
TAB-002MZ-F(E) Anti-Human MET Recombinant Antibody Fab Fragment (TAB-002MZ-F(E)) IHC, PET imaging Chimeric antibody (mouse/human)
TAB-0880CLV Human Anti-MET Recombinant Antibody (TAB-0880CLV) ELISA, FuncS Chimeric (mouse/human) IgG1
TAB-0880CLV-S(P) Mouse Anti-MET Recombinant Antibody; scFv Fragment (TAB-0880CLV-S(P)) ELISA, FuncS Mouse scFv
CAT Product Name Application Type
NEUT-1726CQ Recombinant Rabbit Anti-MET Antibody (CBL1008) Neut IgG
CAT Product Name Application Type
VS-1024-XY131 Mouse Anti-NHP MET Recombinant Antibody (clone K.845.5) WB, IP Mouse IgG1
CAT Product Name Application Type
VS-0325-FY58 Human Anti-Met (clone 5D5) scFv-Fc Chimera Inhib Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC479 Recombinant Anti-MET Vesicular Antibody, EV Displayed (VS-0425-YC479) ELISA, FC, Neut, Cell-uptake
CAT Product Name Application Type
VS-0525-YC10 Recombinant Anti-MET Biparatopic Antibody, Asymmetric hetero HC-LC ELISA Asymmetric hetero HC, common LC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare